{"nct_id":"NCT04700072","title":"Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-05-03","start_date_type":"ACTUAL","primary_completion_date":"2030-04-03","primary_completion_date_type":"ESTIMATED","completion_date":"2030-04-03","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}